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By Anna Deplazes  
 
 PULLQUOTES: 
  
  
Synthetic biology is a new research field that comprises many different projects, 
approaches and definitions, which, at a first glance, do not apparently have much in 
common. These approaches include the generation of bioengineered bacteria, artificial 
protocells or synthetic genomes, as well as pure in silico models of protocells or 
regulatory and metabolic pathways, all of which are products of synthetic biology. This 
viewpoint tries to put these various pieces together by defining five categories or sub-
fields of synthetic biology and looking for their common denominators. These five 
categories are bioengineering, synthetic genomics, the creation of protocells, unnatural 
molecular biology and in silico approaches. For societal and ethical assessments of 
synthetic biology, it is important to consider both, the differences and the similarities 
between the five branches of synthetic biology in order to distinguish between questions 
that affect the field as a whole and those that are specific for individual categories.  
   
The various definitions of synthetic biology in Box 1 indicate that it is not a uniform 
discipline; several commentators and scientists each have individual and varying 
definitions or classifications of synthetic biology (Benner & Sismour, 2005; de Lorenzo 
et al, 2006; Forster & Church, 2007; O'Malley et al, 2008). The five categories proposed 
in this article take into consideration various aspects of these earlier classifications, in 
particular, the scientific disciplines from which the different branches of synthetic 
biology emerged; the stated goals and aims that researchers are striving for; and the 
techniques and strategies that they use to achieve these goals (Table 1). These categories 
should help to make societal assessments of synthetic biology more specific and precise 
by clarifying which issues concern which branches of synthetic biology.  
 
This categorization is clearly open to dispute and certain categories could be combined; I 
do not try to define clear-cut fields of synthetic biology, but rather suggest a possible 
framework within which to arrange individual research projects. Nonetheless, these 
categories, or whatever other definitions and sub-fields one may use and consider, are all 
parts of one research discipline: synthetic biology, the overarching aim of which is to 
create new forms of life either from scratch/de novo, or by redesigning existing life-
forms.  
  
The category that probably attracts most scientists and research funding at present is the 
subfield of bioengineering. It is driven mainly by the idea of turning biotechnology into 
an engineering discipline. The term bioengineering, as used to describe this branch of 
synthetic biology, should not be confused with traditional genetic engineering, which 
introduces singular transgenes into the target organism. The bioengineers of synthetic 
biology have a fundamentally more integral view of how to modify organisms or 
metabolic pathways, which has been adopted from systems biology. For instance, 
inserting a gene that encodes human insulin into bacteria in order to produce transgenic 
protein is classical single-gene genetic engineering. Bioengineering, as part of synthetic 
biology, is the design of entirely new signaling pathways, including multiple genes and 
regulatory elements; for example, an oscillator circuit to trigger the periodic expression 
of GFP-protein in mammalian cells (Tigges et al, 2009). 
 
In contrast to systems biology, which aims to understand complex biological systems, 
such as regulatory networks organisms or even ecosystems, bioengineering tries to design 
novel biological systems by using abstract and simplified metabolic and regulatory 
modules and other standardized parts that can be freely combined into new pathways or 
organisms. This approach not only generates countless possibilities for new applications 
it should also make bioengineering more predictable and controllable than traditional 
biotechnology (Andrianantoandro et al, 2006; Breithaupt, 2006; Endy, 2005; Heinemann 
& Panke, 2006).  
 
The idea of synthetic biology as a bioengineering field is nicely demonstrated by the 
annual international genetically engineered machine competition (iGEM; 
http://2009.igem.org/Main_Page), during which, students, instructed by synthetic 
biologists, engineer novel metabolic pathways in bacteria or human cells based on 
standardized DNA elements, so-called BioBricksTM. Although the iGEM projects have 
not yet lead to scientific breakthroughs—nor have they been developed into fully 
elaborated projects—some examples serve to illustrate what kinds of questions and 
problems can be tackled by synthetic biology. Among the iGEM projects are bacteria that 
are able to differentiate into various cell types analogous to multi-cellular organisms 
(Peking University, 2007), bacteria that are able to do basic mathematical addition (ETH 
Zurich, 2006), bacteria that work as biosensors for arsenic (University of Edinburgh, 
2006), and mammalian cells engineered to prevent sepsis (University of Ljubljana, 2006). 
Some of these projects already anticipate how ‘genetically engineered machines’ could 
be used for bioremediation or medical applications. So far, however, there are only a few 
practical applications of bioengineering that are close to commercial use—such as the 
production of artemisinic acid, the precursor of the anti-malaria drug artemisin (Ro et al, 
2006), or the production of biofuels (Atsumi & Liao, 2008; Lee et al, 2008)—and any 
new products that might result from synthetic biology will require much more research 
and testing before being applied.  
  
While bioengineering focuses on the design and generations of new metabolic and 
regulatory pathways, synthetic genomics emphasises another aspect of synthetic biology, 
namely the creation of organisms with a chemically synthesized (minimal) genome. This 
branch of synthetic biology has been made possible by the constant improvement of 
DNA synthesis technology over the past years, which now allows the generation of DNA 
molecules in the range of thousands of base pairs at a competitive price. The aim is to 
merge these molecules into full genomes and transplant them into living cells, thereby 
replacing the host cell’s genome and reprogramming its metabolism to undertake new 
tasks.  
 
Scientists have already demonstrated the potential of this technology by synthesizing the 
genomes of several viruses and using these synthetic DNA molecules to produce 
infectious viruses. These achievements were huge scientific and technological 
breakthroughs and they provoked the first public discussions about the dangers of this 
technology (Cello et al, 2002; Check, 2002; Check, 2005; Couzin, 2002; Smith et al, 
2003).  
 
Researchers at the J Craig Venter Institute (Rockville, MD, USA) recently published the 
de novo synthesis of the full genome of Mycoplasma genitalium, which comprises more 
than 580,000 base pairs (Gibson et al, 2008). Although, at the time of writing, this 
synthetic genome has not yet been transplanted into a bacterial cell, the fully synthetic 
Mycoplasma genome is considered to be the first step towards the synthesis of bacteria 
with reduced or even minimal genomes. Such organisms, if viable, could provide 
important information about the minimal set of genes and/or functions that are required 
for life.  
 
Furthermore, a minimal genome could serve as a ‘chassis-genome’ that might easily be 
expanded by the addition of genes designed for specific functions. Such ‘chassis 
organisms’ would be optimized for the insertion of novel functions, not only through 
dedicated insertion sites, but also because they would fewer biological pathways that 
potentially interfere with the added functions compared to natural organisms. Much like 
the bioengineering approach, synthetic genomics aims to generate organisms with new 
‘architectures’ and takes an integral or holistic view of the organism. However, in this 
case, the target is not the design of metabolic or regulatory pathways based on abstract 
standards, but the design of chassis-genomes based on essential genes and other requisite 
DNA sequences.   
  
The aim of researchers following the protocell branch of synthetic biology is to construct 
artificial cells in vitro. Such synthetic cells can be built from lipid vesicles, which contain 
the essential metabolic pathways needed to become a fully functional system. Ultimately, 
these synthetic cells should fulfill the necessary criteria to be considered alive, namely, to 
be able to self-reproduce, self-maintain and evolve (Deamer, 2005; Luisi et al, 2006b; 
Sole et al, 2007). While this is the ultimate goal of the protocell approach, there are 
different intermediate stages that do not fulfill all the requirements for a living cell. These 
are lipid vesicles containing cell extract or more specified sets of biological 
macromolecules and complex structures, such as enzymes, nucleic acids or ribosomes, to 
fulfill a certain function—for example, liposomes that could perform specific polymerase 
chain reactions or synthesize a particular protein (Oberholzer et al, 1995, 1999; Luisi et 
al, 2006b; Sole et al, 2007). 
 
Compared to the synthetic genomics approach, which is based on forcing a natural cell to 
follow the instructions encoded by the introduced synthetic genome, protocell synthetic 
biology goes one step further towards a fully artificial organism, as eventually not only 
the genome, but all the components of the cell would be synthesized in vitro. More than 
in any of the other approaches, synthetic biologists in this field consider their work as 
basic research into the minimal requirements for and the origin of life (Luisi, 2006). 
However, the protocell approach also lends itself easily towards applications. Similar to 
other products of synthetic biology, protocells could be used for the synthesis of 
biopolymers and therapeutics (Pohorille & Deamer, 2002; Sole et al, 2007).  
 
The ‘unnatural molecular biology’ approach aims at synthesizing novel forms of life, 
which are based on a new kind of molecular biology, for instance new types of nucleic 
acids or a different genetic code. Alternative forms of nucleic acids could be achieved by 
altering different components of DNA or RNA, such as the bases or the backbone sugars 
(Benner, 2004; Benner & Sismour, 2005; Chin et al, 2003; Wang et al, 2001) to create 
new types of nucleotides that can be assembled into novel nucleic acids.  
 
Modification of the standard genetic code is being tackled by substituting some codons to 
encode for new amino acids, or by inserting quadruplet codons, which would then allow 
the use of non-natural amino acids with novel properties in protein synthesis (Anderson 
et al, 2004; Benner & Sismour, 2005; Xie & Schultz, 2006). Both strategies require the 
enzymatic machineries of the cell to be adapted, which is a scientific and technological 
challenge.  
 
Organisms with such a genome based on unnatural nucleic acids or an entirely new 
coding system for unnatural amino acids would form a new type of life, which would 
present some advantages, but also new risks. On the one hand, there would be no 
outcrossing of genes or horizontal gene transfer with natural organisms upon release into 
the environment. Furthermore, this type of synthetic organisms could be designed to 
depend on non-natural substances for nucleic acid or protein synthesis, such that these 
could not survive in the wild if they escaped spontaneously. On the other hand, if such 
organisms eventually managed to survive outside a controlled environment, they could 
have a selective advantage over natural organisms, as they would be resistant to natural 
viruses or other predatory life forms, which might result in an uncontrolled propagation 
of the synthetic organisms.  
  
In silico synthetic biology is closely linked to the other approaches. One of the main 
challenges of the four discussed synthetic biology approaches is the establishment of 
complicated designs, be it metabolic pathways, basic cellular functions or chassis 
genomes. Similar to systems biology, synthetic biology therefore has a very strong in 
silico branch that seeks to establish computational models for the design of standard 
biological parts or synthetic circuits (Banga, 2008; Marchisio & Stelling, 2008; Simpson, 
2006; Sprinzak & Elowitz, 2005); these are, so to speak, simulations of synthetic 
organisms. The long-term objective of in silico synthetic biology is the practical 
implementation of models and simulations through bioengineering or the other branches 
of synthetic biology (Meyer et al, 2007). However, many of the computational models of 
synthetic organisms to date have little or no direct reference to living organisms. For this 
reason, in silico synthetic biology is considered an independent category in this article.  
  
Each of these categories can be associated with different scientific disciplines: 
bioengineering with biotechnology and engineering, synthetic genomics and the 
molecular biological approach with molecular biology and chemistry, the protocell 
approach with biochemistry and chemistry, and in silico synthetic biology with computer 
sciences. As a result of these different scientific backgrounds, each branch is 
characterized by a specific methodology, strategy and immediate goal. The end product 
of the bioengineering approach ought to be a fully controllable living organism, synthetic 
genomics aims to produce a simplified chassis-organism, while the protocell approach 
would generate an artificial cell that, in contrast to the products of bioengineering, would 
be more autonomous than a human-controlled machine.  
  
Given these differences, does it make sense to combine the five categories into the single 
research field of ‘synthetic biology’? It seems that it does, mainly because these five 
different approaches all contribute to the same goal of generating new forms of living 
organisms, albeit by addressing different aspects of life. such as metabolic regulation, 
minimal components or biochemical composition. Moreover, the different approaches 
start from different methodological strategies, which results in the described variety of 
synthetic biology approaches. 
 
However, it is within the realm of possibility that the different objectives and strategies 
could be combined to create a completely computer-designed organism with a synthetic 
genome of unnatural nucleotides in a lipid vesicle with an engineered metabolism. Even 
before such an organism is achieved, some of these approaches can complement each 
other (Fig 1). The in silico approach, for example, already pervades the other categories; 
synthetic biology is simply not conceivable without computer-based design. Synthetic 
genomes, as a basic chassis to create tailor-made organisms, would of course be a 
powerful tool for bioengineering, while non-natural genomes resulting from the non-
natural molecular biology approach could be used to create synthetic genomes and 
protocells.  
 
In spite of all the methodological and strategic differences, the idea of ‘designing life’ is a 
common theme that underlies all aspects of synthetic biology. ‘Designing’ in this context 
is not used strictly in the sense engineers are using this term, which would imply the 
organized assembly of prefabricated modules and standards. Rather, it refers to the design 
of the overall concept of an organism, which could define its metabolic pathways, its 
genome, its cellular structure or its genetic code. This notion of synthesizing life is 
fundamentally different from, say, the ‘creation of life’ by in vitro fertilization, whereby 
humans cannot directly determine the genotype and phenotype of the organism thus 
generated.   
  
Not surprisingly, synthetic biology has enormous potential implications for society. The 
ability to modify and create life means that scientists could tailor-make organisms to 
fulfill specific functions, such as the production of drugs or other chemicals; the 
production of biofuels or hydrogen; bioremediation of toxic chemicals and various 
applications in medicine, just to name a few. On the other hand, even more than genetic 
engineering, synthetic biology also raises fears about potential abuse, unintended 
environmental damage, health risks or ethical issues. Different stakeholders have already 
begun to discuss these concerns and risks and to propose possible measures. 
Both the possible benefits and possible risks of synthetic biology require broader 
discussion and assessment of the various ethical and societal aspects including biosafety, 
biosecurity, intellectual property rights, and legal and regulatory frameworks. These 
discussions should be guided both by the differences between the various branches of 
synthetic biology, as well as by their common features.   
 
Clearly, the different approaches imply different risks, dangers and ethical issues. A 
report on synthetic genomics for instance, discusses the risks related to the uncontrolled 
synthesis and distribution of pathogenic viruses–a biosecurity issue, which is particularly 
relevant for this approach (Garfinkel et al, 2007). Bioengineering in turn creates worries 
about biosafety related to the handling of such synthetic organisms. Ethical issues can 
also vary between different disciplines. Whereas bioengineering may raise the question of 
whether it is ethical to regard and treat a living organism as a mere machine, the protocell 
approach would raise ethical questions about creating life de novo. In addition to specific 
topics, issues that are specific for certain products or applications of synthetic biology, 
require a case-by-case assessment. The particularly broad spectrum of societal issues that 
seem to be raised by synthetic biology can be partially explained by the fact that this field 
is very heterogeneous, and each branch generates its own issues.  
 
However, in some cases the common features of synthetic biology justify a combined 
assessment. The fact that the products of synthetic biology are ‘alive’—and are thus 
capable of reproducing and evolving—implies particular risks that are not relevant for 
other technological products: for instance, while the release of harmful chemical 
substances or genetically modified organisms are potential risks for the environment, the 
former do not reproduce. Similarly, unlike other technologies, synthetic biology 
synthesizes or substantially modifies living organisms, which may require a specific 
ethical assessment of the whole field (Boldt & Muller, 2008).  
 
Finally, there are many issues related to social impact, global distribution and access to 
the benefits of synthetic biology that should be addressed with a focus on the individual 
branches, in regard to synthetic biology as a whole and in the context of emerging 
technologies in general. 
  
In summary, synthetic biology is not a homogenous discipline, but a heterogeneous 
assembly of different fields and approaches that draw on and are inspired by various 
scientific disciplines. While synthetic biologists may employ different strategies, 
approaches and research tools, they all share the overarching aim of designing and 
creating new forms of life. Any assessment of synthetic biology—be it ethical, legal or 
safety issues—needs to take into account that certain questions, risks and problems are 
specific for each approach; whereas in other cases, it is necessary to regard synthetic 
biology as a whole.   
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Fig 1 | Schematic representation of possible connections between the synthetic 
biology categories.  
1) Computer design established by the in silico approach influences all the other synthetic 
biology approaches. 2) Minimal-chassis organisms synthesized by synthetic genomics 
could be useful for bioengineering. 3) Synthetic genomes could be introduced into 
protocells and 4) the synthetic genomics approach could be used for the synthesis of 
unnatural genome fragments, which 5) could again be used in the protocell approach. 6) 
Unnatural molecular biology could also be used in bioengineering independently of 
protocells. 7) Metabolic pathways engineered by the bioengineering approach could be 
applied in protocells and 8) the pathways found to be required for bioengineering affect 
the models of the in silico approach.  
  
  
Box 1 | Definitions of synthetic biology   
1. “(A) the design and construction of new biological parts, devices and systems and (B) 
the re-design of existing, natural biological systems for useful purposes” 
(http://www.syntheticbiology.org). This definition applies to the categories 
bioengineering, synthetic genomics and in silico synthetic biology. 
2. “The term synthetic biology describes, rather broadly, those avenues of research, 
within the life sciences, interested in the synthesis of parts of biological systems, or in the 
construction of models of biological systems. Synthetic biology comprises (and somehow  
is an extension of) biomimetic chemistry, but with the additional issue of ‘systems 
thinking’”. (Luisi et al, 2006a). This definition describes bioengineering, in silico and 
protocell synthetic biology.  
3. “Synthetic biology is an increasingly high-profile area of research that can be 
understood as encompassing three broad approaches towards the synthesis of living 
systems: DNA-based device construction, genome-driven cell engineering and protocell 
creation. Each approach is characterized by different aims, methods and constructs, in 
addition to a range of positions on intellectual property and regulatory regimes.” 
(O'Malley et al, 2008). This definition describes non-natural molecular biology, 
bioengineering and protocell synthetic biology.  
4. “Synthetic biologists come in two broad classes. One uses unnatural molecules to 
reproduce emergent behaviours from natural biology, with the goal of creating artificial  
life. The other seeks interchangeable parts from natural biology to assemble into systems  
that function unnaturally. Either way, a synthetic goal forces scientists to cross uncharted  
ground to encounter and solve problems that are not easily encountered through 
analysis.” (Benner & Sismour, 2005). This definition describes non-natural molecular 
biology and bioengineering.   
 
Table 1 | Overview of the different synthetic biology approaches  
 Scientific 
background 
Vision Technique Notable societal 
impact  
 
Bioengineering Engineering, 
Biotechnology 
Making biology  
an engineering  
discipline 
Standardized 
and  
elaborated 
genetic  
engineering 
Biosafety: 
Interaction with  
Environment. 
Ethics: turning 
organisms into  
machines  
 
Synthetic  
Genomics 
Molecular 
Biology, 
Chemistry 
Chassis-
organism 
DNA synthesis Biosecurity: 
synthesis of 
pathogens 
Protocell 
synthetic 
biology 
Chemistry, 
Biochemistry 
Synthetic cell Chemical 
synthesis of a  
cell 
Ethics: in vitro 
synthesis of life 
Unnatural  
Molecular  
Biology  
 
Chemistry, 
Biochemistry, 
Molecular 
biology  
“Parallel life” Synthesis of 
unnatural  
genomes and 
biological  
adaptation of 
the cell 
Ethics: in vitro 
synthesis of 
life. 
Biosafety: 
resistant to 
viruses  
 
In silico 
synthetic 
biology 
Computer 
science, 
Engineering 
Designed  
organisms 
Computer 
technology 
Only as applied 
to other 
approaches 
In common New forms of 
life, Designed 
life 
  Biosafety, 
Biosecurity 
depending on 
applications. 
Ethics: 1) 
related to the 
impact on  
society 2) 
related to 
dealing with 
life  
 
 
